Back to Journals » Advances in Genomics and Genetics » Volume 2

Epigenetics and stroke risk – beyond the static DNA code

Authors Matouk CC, Turgeon PJ, Marsden PA

Received 18 July 2012

Accepted for publication 3 September 2012

Published 16 October 2012 Volume 2012:2 Pages 67—84

DOI https://doi.org/10.2147/AGG.S18697

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Charles C Matouk,1 Paul J Turgeon,2 Philip A Marsden2,3

1
Department of Neurosurgery, Yale University School of Medicine, New Haven, CT, USA; 2Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada; 3Keenan Research Centre and Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, Canada

Abstract: Advances in high-throughput genome sequencing and genome-wide association studies indicate that only a fraction of estimated variability in stroke risk can be explained by genetic variation in protein-coding genes alone. Epigenetics is defined as chromatin-based mechanisms important in the regulation of gene expression that do not involve changes in the DNA sequence per se. Epigenetics represents an alternative explanation for how traditional risk factors confer increased stroke risk, provide a newer paradigm to explain heritability not explained by genetic variation, and provide insight into the link between how the environment of a cell can interact with the static DNA code. The nuclear-based mechanisms that contribute to epigenetic gene regulation can be separated into three distinct but highly interrelated processes: DNA methylation and hydroxymethylation; histone density and posttranslational modifications; and RNA-based mechanisms. Together, they offer a newer perspective on transcriptional control paradigms in blood vessels and provide a molecular basis for understanding how the environment impacts the genome to modify stroke susceptibility. This alternative view for transcriptional regulation allows a reassessment of the cis/trans model and even helps explain some of the limitations of current approaches to genetic-based screens. For instance, how does the environment exert chronic effects on gene expression in blood vessels after weeks or years? When a vascular cell divides, how is this information transmitted to daughter cells? This review provides an introduction to epigenetic concepts and a conceptual framework for understanding the shortcomings of an approach to stroke research that focuses solely on the static DNA code. Additionally, it will discuss classical and emerging mechanisms of epigenetic gene regulation that are especially relevant to large-vessel ischemic stroke.

Keywords: DNA methylation, endothelial nitric oxide synthase, histone posttranslational modifications, long noncoding RNA, ANRIL, heritability

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF] 

 

Readers of this article also read:

Analysis of serum phosphate control and phosphate binder utilization in incident hemodialysis patients

Farrand KF, Copley JB, Heise J, Fridman M, Keith MS, Poole L

International Journal of Nephrology and Renovascular Disease 2014, 7:261-269

Published Date: 5 July 2014

Acute kidney injury: what part do toll-like receptors play?

Vallés PG, Gil Lorenzo A, Bocanegra V, Vallés R

International Journal of Nephrology and Renovascular Disease 2014, 7:241-251

Published Date: 19 June 2014

Progression of nuclear sclerosis based on changes in refractive values after lens-sparing vitrectomy in proliferative diabetic retinopathy

Ikeda T, Minami M, Nakamura K, Kida T, Fukumoto M, Sato T, Ishizaki E

Clinical Ophthalmology 2014, 8:959-963

Published Date: 16 May 2014

Aneuploidogenic effects and DNA oxidation induced in vitro by differently sized gold nanoparticles

Di Bucchianico S, Fabbrizi MR, Cirillo S, Uboldi C, Gilliland D, Valsami-Jones E, Migliore L

International Journal of Nanomedicine 2014, 9:2191-2204

Published Date: 8 May 2014

Preparation and efficacy of Newcastle disease virus DNA vaccine encapsulated in chitosan nanoparticles

Zhao K, Zhang Y, Zhang XY, Li W, Shi C, Guo C, Dai CX, Chen Q, Jin Z, Zhao Y, Cui HY, Wang YF

International Journal of Nanomedicine 2014, 9:389-402

Published Date: 7 January 2014

Existing data sources for clinical epidemiology: the Danish Quality Database of Mammography Screening

Langagergaard V, Garne JP, Vejborg I, Schwartz W, Bak M, Lernevall A, Mogensen NB, Larsson H, Andersen B, Mikkelsen EM

Clinical Epidemiology 2013, 5:81-88

Published Date: 14 March 2013

Labeling and exocytosis of secretory compartments in RBL mastocytes by polystyrene and mesoporous silica nanoparticles

Ekkapongpisit M, Giovia A, Nicotra G, Ozzano M, Caputo G, Isidoro C

International Journal of Nanomedicine 2012, 7:1829-1840

Published Date: 4 April 2012